Albert David Limited has informed the Exchange about Copy of Newspaper Publication dated 04.08.2025
ALBERTDAVD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Albert David Limited, a Kolkata-based pharmaceutical company, has published its unaudited financial results for Q1 FY26 (quarter ended June 30, 2025) in Financial Express and Aajkaal newspapers, as required under SEBI Listing Regulations. Total income from operations stood at Rs. 7,056.64 lakhs, down about 21% from Rs. 8,935.64 lakhs in the same quarter last year. Net profit after tax came in at Rs. 703.76 lakhs, a sharp decline of roughly 63% compared to Rs. 1,884.44 lakhs in Q1 FY25. Basic and diluted EPS for the quarter was Rs. 13.91 versus Rs. 33.02 a year ago. The statutory auditors issued an unmodified review report, and the results were approved by the board on August 2, 2025. The company operates in a single pharmaceutical manufacturing segment under Ind AS-108.
This filing is mainly a regulatory newspaper publication of already-disclosed Q1 numbers; there is no new information for shareholders. However, the underlying results point to a significant year-on-year drop in both revenue and profitability, which could weigh on short-term sentiment for the stock.